TBBCF funds four grants for breast cancer research By KATHLEEN EDGECOMB The Terri Brodeur Breast Cancer Foundation has awarded $400,000 in research grants to four women who are trying to find a cure for breast cancer and are searching for better ways to treat those who are diagnosed with cancer, “There is an energy and […]
TBBCF awards $400,000 for research Read More »
Big Y is spreading TBBCF message In February, Big Y in Groton will donate $1 to the Terri Brodeur Breast Cancer Foundation for every reusable grocery bag it sells at the checkout line. TBBCF has been chosen by the Big Y at 905 Poqunnock Road, as the latest non-profit to benefit from the Community Bag
It’s all in the bag at Big Y Read More »
Laura Spring, MD Massachusetts General Hospital Localized breast cancer patients with higher risk disease are often treated with chemotherapy in the neoadjuvant (before surgery) setting. However, it is difficult to predict how breast cancer will respond to treatment given in the neoadjuvant setting and we currently lack any specific blood tests to help answer this
Jing Hu, PhD Memorial Sloan Kettering Cancer Center Metastasis is a major clinical hurdle in breast cancer treatment, with poor prognosis (5-year survival around 26.5%). Despite surgical resection of the primary tumor and systemic therapy to suppress residual disease, distant metastatic relapse may still occur within a few months to years, implying the existence of
Veerle Daniels, PhD Dana-Farber Cancer Institute Despite recent advances in treatment options, breast cancer remains the second leading cause of cancer-related deaths in women. Triple negative breast cancer (TNBC) is a subgroup of breast cancer that is characterized by the absence of the estrogen receptor, the progesterone receptor and HER2-amplification. Because of the lack of these
Veerle Daniels, PhD Read More »
Ana Garrido-Castro, MD Dana-Farber Cancer Institute Choosing the best treatments for metastatic breast cancer depends increasingly on molecular features, such as tumor subtype. Patients with hormone receptor-positive/HER2-negative breast cancer are typically treated initially with hormonal therapies, and then subsequently with chemotherapy once hormonal therapy loses its effectiveness. Loss of hormone receptor expression has been described as a
Ana Garrido-Castro, MD Read More »
College student is link between researchers and scientific advisory board By KATHLEEN EDGECOMB Gabby Gualtieri was 10 or 11 when she first became involved with the Terri Brodeur Breast Cancer Foundation. She remembers handing out drinks, snacks and candy with her family to participants during the annual Walk Across Southeastern Connecticut fundraiser. “The marathon was
New volunteer steps in as TBBCF liaison Read More »
Director of Development and Outreach Terri Brodeur Breast Cancer Foundation – New London, CT 06320 We have an exciting part-time opportunity for a Director of Development and Outreach to be part of an organization whose goal is to find a cure for breast cancer. Read Job Description To apply for the position please send your resume to [email protected]
Part-time job opportunity with TBBCF Read More »
